Business Context and Reporting Period
Company: Molina Healthcare, Inc.
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2009
Business Overview: Molina is a multi-state managed care organization providing health services to Medicaid, Medicare, and other government-sponsored program beneficiaries. As of December 31, 2009, the company operated licensed health plans in nine states (California, Florida, Michigan, Missouri, New Mexico, Ohio, Texas, Utah, and Washington) with approximately 1,455,000 members. The company ceased operations in Nevada effective January 1, 2010.
Key Financial Metrics
| Metric | 2009 | 2008 |
|---|---|---|
| Total Revenue | $3,669.4 million | $3,112.4 million |
| Premium Revenue | $3,660.2 million | $3,091.2 million |
| Net Income | $30.9 million | $59.6 million |
| Diluted EPS | $1.19 | $2.15 |
| Medical Care Ratio | 86.8% | 84.8% |
| G&A Expense Ratio | 10.9% | 11.1% |
| Cash and Cash Equivalents | $469.5 million | $387.2 million |
| Long-Term Debt | $158.9 million | $164.9 million |
| Stockholders' Equity | $542.7 million | $531.8 million |
Material Changes vs. Prior Period
- Profitability Decline: Net income decreased 48% to $30.9 million from $59.6 million in 2008. Diluted EPS fell to $1.19 from $2.15.
- Medical Cost Ratio Deterioration: The medical care ratio increased to 86.8% from 84.8%. Management attributed this to higher utilization due to widespread H1N1 influenza (estimated incremental cost of $35 million), higher emergency room costs, and the higher costs associated with rapid enrollment growth.
- Revenue Growth: Premium revenue grew 18% year-over-year, driven by a 16% increase in membership (adding ~200,000 members) and a 5.3% increase in per-member-per-month (PMPM) revenue.
- State Budget Impacts: Margin compression occurred in Washington and Missouri due to premium reductions that were not fully commensurate with decreases in Medicaid fee schedules. Missouri also carved out the pharmacy benefit effective October 1, 2009.
- Investment Income: Decreased to $9.1 million from $21.1 million due to lower interest rates.
Guidance, Outlook, and Risks
- Acquisition Activity: On January 18, 2010, the company entered a definitive agreement to acquire the Health Information Management (HIM) business of Unisys Corporation for approximately $135 million. This acquisition is expected to close in the first half of 2010 and will be funded via the company's credit facility.
- Regulatory Risks: The company faces significant risk from state budget deficits, which may lead to funding cuts, rate reductions, or changes in eligibility thresholds. The temporary federal Medicaid matching rate increase (ARRA) is set to expire December 31, 2010, creating uncertainty for future state funding.
- Medical Cost Volatility: Profitability is highly sensitive to medical care cost ratios. A 1% increase in the medical care ratio could reduce earnings by approximately 85%.
- Contract Renewals: The company relies on a limited number of state contracts. Failure to renew contracts or win new bids could materially reduce revenue.
- Investment Portfolio: The company holds auction rate securities with a fair value of $23.0 million (par value $26.9 million). While deemed temporary impairments, liquidity issues in the auction market pose a risk.
Investor Verification Checklist
- Medical Cost Reserves: Verify the adequacy of Incurred But Not Paid (IBNP) reserves, as a 1% change in completion factors could impact net income by approximately $7.5 million.
- State Funding Stability: Monitor state budget announcements in key operating states (California, Ohio, Washington) for potential rate cuts or benefit carve-outs.
- HIM Acquisition Integration: Assess the progress and regulatory approval status of the Unisys HIM acquisition and its impact on leverage ratios.
- Contract Renewals: Track the renewal status of major state contracts, particularly those expiring in 2010 (e.g., Michigan, Missouri, Ohio, Texas, Utah, Washington).
- Flu Season Impact: Evaluate whether the H1N1-related cost increases in 2009 were a one-time anomaly or indicative of a new utilization trend.